A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions
NCT ID: NCT07042191
Last Updated: 2025-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2022-12-09
2027-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* complete a baseline survey
* attend two one on one meetings, one as part of the development and the second as part of the pilot testing of the intervention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer
NCT04766190
Feasibility and Utilization of an Application-based Question Prompt List
NCT03676920
Patient-Centered Intervention to Reduce Cancer Patients' Financial Toxicity
NCT04314284
Interventions to Decrease Financial Toxicity
NCT05939440
Cost Talk: Discussing Cancer Care Costs
NCT04397016
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To achieve Aim 1, participants will be asked to complete a survey eliciting their demographic and professional characteristics prior to interviews. Then, during one-on-one interviews, which will be audio recorded and subsequently transcribed, the investigators will present the DISCO Provider wireframes and ask participants to provide feedback on the planned content, organization, and implementation. The Investigators will also present participants with strategies identified from research on how to initiate, respond to, and effectively discuss cost concerns. Investigators will ask participants about ideas for website design and training intervention implementation. Participants will be asked to complete a needs assessment interview about their use of digital support tools.
To achieve Aim 2 and pilot test DISCO Provider, participants will again meet one-on-one with the Investigators. Investigators will ask participants to provide feedback on the acceptability and usability of the working version of DISCO Provider, whether participants think it is useful for training providers to discuss cost, if the strategies suggested will likely be effective, and suggestions for improvement. Meetings will be audio recorded, transcribed, and analyzed using similar methods as those in Aim 1
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DISCO (Discussions of Cost) Provider Companion Intervention
Providers of Cancer patients at Karmanos Cancer Institute will use the DISCO (Discussion of Cost) provider communication intervention to assess its feasibility, acceptability, and usability
Disco (Discussion of Cost) Provider Companion Intervention
A communication intervention for providers to assess financial toxicity in Cancer patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Disco (Discussion of Cost) Provider Companion Intervention
A communication intervention for providers to assess financial toxicity in Cancer patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Barbara Ann Karmanos Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lauren Hamel
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lauren M Hamel, PhD
Role: PRINCIPAL_INVESTIGATOR
Wayne State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karmanos Cancer Institute
Detroit, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-085
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.